Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
13:23 CanaryDwarf, spot on! Sitting tight, though currently not enjoying the ride. Not selling a single share below the nav. Not selling at nav as well btw. Too much upside potential, would be embarrassed... This is not like a exploration share, nor a financial. This is well balanced, with a strong position in disruptive markets. Lots are talking about Belluscura and Salarius and won't disagree, but the more I read about it, the more I see the massive impact Guident will make.
KR
GS
14:12 Cizur, fully agree! I may be over-positive, but with a current nav of 0,30/share and a current sp of 0,15, I would estimate an sp after FDA approval between 30 and 50p, in april 2021 100p, and 2022 maybe dividend :-)
KR
GS
The sun is shining...
Wouldn't be surprised to see info within the coming days about FDA and a couple of days later about Salarius.
What they call a multi stage rocket
Herd will arrive shortly, I am afraid. So far for peace and quiet on this BB.... :-)
KR
GS
Afternoon all,
Apart from my feeling that the timing of the capital raise couldn’t have been better, I still am patiënt very often, just not very long... Does anybody have any experience with timings of approvals? I.e. is there a particular time in the day the FDA makes announcements about approvals?
KR
GS